ReviewOncology letters2025

Novel clinical potential of poly (ADP‑ribose) polymerase inhibitors in triple‑negative breast cancer: Mechanistic insights and clinical applications (Review).

Yu Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.